Bristol Myers Squibb Co SEC filings BMY

Bristol Myers Squibb Co has 1,002 filings in SEC EDGAR's recent list, going back to Apr 2, 2019. Its latest annual report, Form ARS, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 25, 2026 Dec 31, 2025
10-K Annual report Feb 11, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 26, 2025 Dec 31, 2024
10-K Annual report Feb 12, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 28, 2024 Dec 31, 2023
10-K Annual report Feb 13, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 23, 2023 Dec 31, 2022
10-K Annual report Feb 14, 2023 Dec 31, 2022
10-K Annual report Feb 9, 2022 Dec 31, 2021
10-K Annual report Feb 10, 2021 Dec 31, 2020
10-K Annual report Feb 24, 2020 Dec 31, 2019

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BMY (NYSE), CELG-RI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Large accelerated filer
SEC CIK
14272

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.